Editas Medicine
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $24,741 | $7,543 | $3,578 | $4,658 |
Gross Profit | 24,741 | 7,543 | 3,578 | 4,658 |
EBITDA | -5,279 | -21,997 | -49,381 | -71,955 |
EBIT | -6,084 | -22,718 | -51,215 | -73,872 |
Net Income | -5,620 | -25,117 | -53,235 | -76,088 |
Net Change In Cash | 24,741 | 7,543 | 3,578 | 4,658 |
Free Cash Flow | -36,447 | -31,276 | -50,212 | -47,913 |
Cash | 146,645 | 165,648 | 138,542 | 138,692 |
Basic Shares | 88,745 | 90,090 | 84,412 | 83,055 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $40,520 | $32,314 | $78,123 | $19,712 |
Gross Profit | 40,520 | 32,314 | 72,059 | 19,712 |
EBITDA | -148,612 | -233,111 | -163,117 | -219,613 |
EBIT | -153,889 | -238,920 | -169,181 | -225,950 |
Net Income | -160,060 | -237,093 | -153,219 | -204,352 |
Net Change In Cash | 40,520 | 32,314 | 78,123 | 19,712 |
Cost of Revenue | -61,997 | |||
Free Cash Flow | -165,848 | -219,110 | -136,897 | -181,467 |
Cash | 146,645 | 131,541 | 123,652 | 141,522 |
Basic Shares | 88,745 | 82,338 | 75,965 | 68,664 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.06 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.63 |
2025-03-31 | -$0.92 |
